| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $22.6M | -18.7% |
| SG&A Expense | $13.8M | -10.0% |
| Operating Income | -$36.3M | +15.6% |
| Interest Expense | $4.7M | +10.8% |
| Pre-tax Income | -$38.5M | +13.2% |
| Income Tax | -$869K | +38.2% |
| Net Income | -$37.6M | +12.4% |
| EPS (Basic) | -$1.03 | +25.9% |
| EPS (Diluted) | -$1.03 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.7M | -26.3% |
| Current Assets | $45.1M | -23.7% |
| Total Assets | $45.4M | -23.6% |
| Current Liabilities | $17.1M | +25.4% |
| Total Liabilities | $26.4M | -20.8% |
| Stockholders' Equity | $19.0M | -27.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$35.0M | -4.1% |
| Capital Expenditures | $29K | — |
| Investing Cash Flow | -$29K | — |
| Financing Cash Flow | $20.2M | +23.3% |
| Free Cash Flow | -$35.1M | -4.2% |
| +25.9% |